bioMerieux-PierreFabre

BioMerieux designs, develops, manufactures, and markets in vitro diagnostic systems for clinical and industrial applications. The company's diagnostic systems include reagents and consumables for conducting biological tests used in screening, diagnostic assistance, prognosis, and therapeutic monitoring; instruments, platforms, and automated analyzers for high-throughput or low-throughput automated testing; software for processing analyses and interpreting biological test results; and other related services such as instrument installation and maintenance, user training, and laboratory workflow audits.